AlphAIAlphAI — Financial news for AI agents
prnewswire.comSEP 182 min read$COO

JANA Partners Sends Letter to Cooper Board of Directors

JANA Partners sent a letter to The Cooper Companies' board, citing chronic underperformance and calling for an external CEO search, new board chair, and asset sales. The firm highlights poor forecasting, capital allocation, and share price underperformance. JANA urges immediate action to improve shareholder value and engage with potential buyers for CooperVision and CooperSurgical assets.

Original reporting
prnewswire.com
Published Sep 18, 2026, 11:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 12:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$COO
Bearish
medium confidence
Mentioned
$COO
Relevance
5/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$COOBearishLow
01

Why it matters

The letter signals possible governance changes and strategic asset sales, which could affect Cooper's valuation and investor confidence.

02

Market read

First disclosure of activist pressure on COO; may prompt short‑term volatility and longer‑term strategic shifts.

03

What to watch

Potential hidden support from large shareholders or upcoming earnings that could shift sentiment.

Relevance 5/10Novelty 6/10Timing: Sept 18 2026 (today)

Background

JANA Partners, a known activist investor, publicly urged Cooper Companies' board to take immediate actions to improve performance.

Company-level read

Ticker impact

$COOBearishMedium confidence
Context

JANA Partners sent a public letter urging Cooper Companies' board to replace the CEO, appoint a new chair, and consider asset sales.

Expected impact

possible short‑term downside as investors assess governance risk; upside if board acts decisively.

Evidence & confidence

The letter is the first public disclosure of activist intent; market reaction will depend on board response.

Market effects

Sector

Highlights governance risk in the medical device sector, may prompt peers to review board structures.

Regional

U.S. healthcare stocks could see modest pressure from activist scrutiny.

Global

Limited to investors tracking activist campaigns in U.S. listed companies.

Counterpoint

What could challenge this read

Board may reject activist demands, leading to a rally if investors view the push as overreach.

Key entities

  • Activist Investor
    JANA Partners

    Manager of funds that own a stake in Cooper Companies and is pushing for board changes.

  • Company
    The Cooper Companies, Inc.

    Medical device and vision care firm targeted by activist letter.

Read at source← All news

Related articles

SEP 21
$COOMedAI 8/10

A Failed Auction and a 15% Drop: Is Cooper Companies (COO) a Value Trap or a Bargain?

Cooper Companies (COO) ended its 9-month effort to sell CooperSurgical after bids undervalued the business, according to management. The stock dropped 15% to a 52-week low near $51 after a Q3 miss and cut outlook. The company's core contact lens business, CooperVision, posted flat organic revenue growth, contributing to the guidance cut. Management authorized a $1B share repurchase program, while Bank of America questioned the valuation. COO reported record Q3 free cash flow of $273M.

insidermonkey.com2 min
SEP 14
$COOMedAI 8/10

The Cooper Companies (COO) Faces Near-Term Pressure from Slowing Contact Lens Demand

The Cooper Companies (COO) lowered its fiscal 2026 profit and revenue forecasts due to weaker-than-expected contact lens demand, with adjusted EPS now expected at $4.51–$4.55 and revenue at $4.23–$4.25 billion. Q3 revenue was $1.07 billion, missing estimates, though adjusted EPS beat at $1.15. The company cited U.S. channel inventory reductions as a key factor and decided to retain CooperSurgical.

finance.yahoo.com3 min
SEP 11
$COOMedAI 8/10

Cooper Companies (COO) Bets on Fertility Growth Despite Weakness in CooperVision

Cooper Companies (COO) reported Q3 FY2026 revenue of $1.066B, up 1%, and adjusted EPS of $1.15, up 4%. The company spent $339.1M on share buybacks and has $1.5B remaining in repurchase capacity. Fertility segment growth and strong cash flow offset weakness in CooperVision, which saw flat organic growth and revenue declines in Americas and Asia Pacific. Gross margin improved to 67% on a GAAP basis, while adjusted operating margin rose 30 basis points to 26%.

yahoo.com2 min
SEP 11
$COOMed

Why Cooper, Freeport-McMoRan, and Baker Hughes Plunged

Cooper Companies (COO) fell 14.67% after reporting Q3 revenue of $1.07B and Q4 guidance below estimates. Freeport-McMoRan (FCX) dropped 6.59% due to White House uncertainty on copper tariffs. Baker Hughes (BKR) declined 6.66% despite raising its full-year revenue guidance to $28.5B-$30.3B.

baystreet.ca2 min